MedPath

Ohio State University Comprehensive Cancer Center

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.cancer.osu.edu

Nutritional Supplements & Complementary/Alternative Medicine by Prostate & Breast Cancer Patients

Completed
Conditions
Breast Cancer
Prostate Cancer
First Posted Date
2013-04-04
Last Posted Date
2024-02-05
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
109
Registration Number
NCT01823549
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

2 Phase Comparison of Pre-operative CT and PET Images for Metastatic Colorectal Cancer

Phase 2
Completed
Conditions
Stage IV A Bladder Cancer
Stage IV B Colon Cancer
Recurrent Colon Cancer
Recurrent Rectal Cancer
Stage IV A Rectal Cancer
Stage IV B Rectal Cancer
Interventions
Procedure: PET Scan
Procedure: CT Scan
Radiation: fludeoxyglucose F 18
Procedure: computer-aided detection/diagnosis
First Posted Date
2013-03-29
Last Posted Date
2016-03-02
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
21
Registration Number
NCT01821105
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Ohio State University Medical Center, Columbus, Ohio, United States

Lymph Node Mapping in Patients With Endometrial Cancer

Not Applicable
Completed
Conditions
Endometrial Cancer
Interventions
Procedure: sentinel lymph node detection
Procedure: sentinel lymph node biopsy
First Posted Date
2013-03-26
Last Posted Date
2023-03-22
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
204
Registration Number
NCT01818739
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, United States

๐Ÿ‡บ๐Ÿ‡ธ

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States

Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental Care

Not Applicable
Completed
Conditions
Tongue Cancer
Oral Cavity Verrucous Carcinoma
Stage 0 Lip and Oral Cavity Cancer
Lip and Oral Cavity Squamous Cell Carcinoma
Interventions
Procedure: fluorescence imaging
Procedure: biopsy
Procedure: examination
Procedure: Comparison of surgical margins by COE vs. DVFE
First Posted Date
2013-03-22
Last Posted Date
2020-01-30
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
68
Registration Number
NCT01816841
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States

Alisertib With and Without Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Phase 2
Terminated
Conditions
Recurrent Grade 1 Follicular Lymphoma
Recurrent Grade 2 Follicular Lymphoma
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
Nodal Marginal Zone B-cell Lymphoma
Recurrent Adult Burkitt Lymphoma
Recurrent Adult Diffuse Large Cell Lymphoma
Recurrent Marginal Zone Lymphoma
Splenic Marginal Zone Lymphoma
Waldenstrรถm Macroglobulinemia
Recurrent Grade 3 Follicular Lymphoma
Interventions
Biological: rituximab
Other: laboratory biomarker analysis
First Posted Date
2013-03-15
Last Posted Date
2018-06-06
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
14
Registration Number
NCT01812005
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States

๐Ÿ‡บ๐Ÿ‡ธ

Emory University, Atlanta, Georgia, United States

Patient Activation Intervention in Improving Screening Rates for Colorectal Cancer

Not Applicable
Completed
Conditions
Rectal Cancer
Colon Cancer
Interventions
Other: educational intervention
Other: questionnaire administration
First Posted Date
2013-02-28
Last Posted Date
2014-10-16
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
284
Registration Number
NCT01801059
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States

Methylprednisolone Before Fludeoxyglucose-Labeled Positron Emission Tomography in Patients With Lung Cancer

Not Applicable
Withdrawn
Conditions
Lung Cancer
Interventions
Radiation: fludeoxyglucose F 18
Procedure: positron emission tomography
Procedure: computed tomography
First Posted Date
2013-02-12
Last Posted Date
2018-06-28
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Registration Number
NCT01789892

Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer

Phase 2
Completed
Conditions
Ovarian Sarcoma
Stage I Uterine Sarcoma
Stage I Vulvar Cancer
Stage IA Ovarian Epithelial Cancer
Stage IC Fallopian Tube Cancer
Stage IIA Fallopian Tube Cancer
Stage IIA Ovarian Germ Cell Tumor
Stage IIIA Ovarian Germ Cell Tumor
Stage IIIB Endometrial Carcinoma
Stage IIIB Fallopian Tube Cancer
Interventions
Other: behavioral, psychological or informational intervention
First Posted Date
2013-01-10
Last Posted Date
2018-05-30
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
100
Registration Number
NCT01764802
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States

Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer

Not Applicable
Completed
Conditions
Recurrent Endometrial Carcinoma
Recurrent Ovarian Epithelial Cancer
Recurrent Vulvar Cancer
Fatigue
Leydig Cell Tumor
Recurrent Primary Peritoneal Cavity Cancer
Pain
Anxiety Disorder
Depression
Peritoneal Carcinomatosis
Interventions
Other: questionnaire administration
Procedure: quality-of-life assessment
Procedure: psychosocial assessment and care
Behavioral: behavioral intervention
Other: cognitive intervention
Other: educational intervention
First Posted Date
2013-01-10
Last Posted Date
2015-10-09
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
39
Registration Number
NCT01764789
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Ohio State University Medical Center, Columbus, Ohio, United States

Cognitive Therapy in Reducing Depression in Patients With Cancer

Phase 2
Completed
Conditions
Depression
Interventions
Procedure: quality-of-life assessment
Other: questionnaire administration
Other: counseling intervention
Behavioral: behavioral intervention
First Posted Date
2012-12-12
Last Posted Date
2015-06-04
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
25
Registration Number
NCT01748734
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Ohio State University Medical Center, Columbus, Ohio, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath